CYTOGEN

The current price of 217330 is 12550 KRW — it has decreased by 1.41% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange CYTOGEN stocks are traded under the ticker 217330.

217330 stock is 6.64% volatile and has beta coefficient of 0.50. Check out the list of the most volatile stocks — is CYTOGEN there?

Yes, you can track CYTOGEN financials in yearly and quarterly reports right on TradingView.

217330 stock has fallen by 3.46% compared to the previous week, the month change is a 14.16% fall, over the last year CYTOGEN has showed a 34.97% decrease.

217330 net income for the last quarter is ‪−7.23 B‬ KRW, while the quarter before that showed ‪−2.76 B‬ KRW of net income which accounts for −162.14% change. Track more CYTOGEN financial stats to get the full picture.

No, 217330 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, 217330 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CYTOGEN stock right from TradingView charts — choose your broker and connect to your account.

217330 reached its all-time high on Aug 12, 2021 with the price of 24170 KRW, and its all-time low was 2270 KRW and was reached on Mar 19, 2020.
See other stocks reaching their highest and lowest prices.

As of Apr 19, 2024, the company has 49.00 employees. See our rating of the largest employees — is CYTOGEN on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CYTOGEN technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CYTOGEN stock shows the strong sell signal. See more of CYTOGEN technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CYTOGEN EBITDA is ‪−9.91 B‬ KRW, and current EBITDA margin is −311.83%. See more stats in CYTOGEN financial statements.